FCAS
MRNA icon

First Command Advisory Services’s Moderna MRNA Stock Holding History

First Command Advisory Services’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$43.2K Sell
850
-2
-0.2% -$93 ﹤0.01% 373
2025
Q4 		$25.1K Sell
852
-750
-47% -$20.4K ﹤0.01% 395
2025
Q3 		$41.4K Hold
1,602
– – ﹤0.01% 325
2025
Q2 		$44.2K Hold
1,602
– – ﹤0.01% 298
2025
Q1 		$45.4K Hold
1,602
– – ﹤0.01% 285
2024
Q4 		$66.6K Hold
1,602
– – ﹤0.01% 251
2024
Q3 		$107K Hold
1,602
– – ﹤0.01% 220
2024
Q2 		$190K Sell
1,602
-4
-0.2% -$506 ﹤0.01% 156
2024
Q1 		$171K Buy
1,606
+4
+0.2% +$403 ﹤0.01% 161
2023
Q4 		$159K Hold
1,602
– – ﹤0.01% 157
2023
Q3 		$165K Buy
+1,602
New +$179K ﹤0.01% 153

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return